UTHR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue Jasper Therapeutics JSPR Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher IESC Q1 2026 Earnings EPS Surges 35 Above Expectations Stock Rises GLDD Q4 2025 Earnings Strong EPS Surprise of 545 as Dredging Operations Beat Estimates